Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- LRMR
- Price
- 3.45
- Stock movement up
- +0.13 (3.92%)
- Company name
- Larimar Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 286.66M
- Ent value
- 244.83M
- Price/Sales
- 594.73
- Price/Book
- 2.06
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -23.21%
- 1 year return (CAGR)
- 0.58%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
LRMR does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 594.73 |
| Price to Book | 2.06 |
| EV to Sales | 507.95 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 83.09M |
| EPS (TTM) | -1.69 |
| FCF per share (TTM) | -1.24 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 482.00K |
| Gross profit (TTM) | 66.00K |
| Operating income (TTM) | -139.77M |
| Net income (TTM) | -132.00M |
| EPS (TTM) | -1.69 |
| EPS (1y forward) | -1.82 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 13.69% |
| Operating margin (TTM) | -28998.34% |
| Profit margin (TTM) | -27385.68% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 90.14M |
| Net receivables | 1.00M |
| Total current assets | 183.22M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 4.79M |
| Total assets | 187.35M |
| Accounts payable | 11.10M |
| Short/Current long term debt | 4.35M |
| Total current liabilities | 45.12M |
| Total liabilities | 48.31M |
| Shareholder's equity | 139.04M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -96.49M |
| Capital expenditures (TTM) | 270.00K |
| Free cash flow (TTM) | -96.76M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -94.94% |
| Return on Assets | -70.46% |
| Return on Invested Capital | -94.16% |
| Cash Return on Invested Capital | -69.02% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.33 |
| Daily high | 3.62 |
| Daily low | 3.31 |
| Daily Volume | 999K |
| All-time high | 616.08 |
| 1y analyst estimate | 16.70 |
| Beta | 1.05 |
| EPS (TTM) | -1.69 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| LRMR | S&P500 | |
| Current price drop from All-time high | -99.44% | -0.89% |
| Highest price drop | -99.72% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -99.37% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
286.66M
Marketcap category
Small-cap
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Employees
65
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page